Suppr超能文献

住院肾病患者的诊断相关分组、资源利用、年龄及预后

Diagnosis related groups, resource utilization, age, and outcome for hospitalized nephrology patients.

作者信息

Muñoz E, Thies H, Maesaka J K, Angus G, Goldstein J, Wise L

机构信息

Department of Medicine, Long Island Jewish Medical Center, New Hyde Park 11042.

出版信息

Am J Kidney Dis. 1988 Jun;11(6):481-8. doi: 10.1016/s0272-6386(88)80084-2.

Abstract

Economic incentives are rapidly changing for hospitals under the prospective Diagnosis Related Group (DRG) hospital reimbursement scheme. The purpose of this project was to study resource use, age, and outcome for nephrology admissions to a large academic medical center. Total hospital costs for the 784 nephrology admissions (January 1, 1985 to December 31, 1986) were $5,037,460. Mean hospital cost per patient and mortality generally increased with age. DRG payment for patients in the 13 nephrology DRGs analyzed would have produced an aggregate loss of $483,584; however, all age categories of patients 55 years of age and over generated significant losses (the highest was for patients 85 years and above, $5,343 loss per patient). Diabetic nephrology patients generated greater resource consumption compared with nondiabetic nephrology patients, as well as patients in medical and surgical DRGs with chronic renal failure compared with patients in these same DRGs without chronic renal failure. Older nephrology patients also demonstrated higher emergency and ICU admission and blood requirements than younger patients. This study suggests that the current DRG reimbursement scheme may be inequitable vis a vis older nephrology patients, as well as those with diabetes mellitus and chronic renal failure. Financial disincentives by DRGs may affect both the access and quality of care for groups of nephrology patients in the future.

摘要

在预期诊断相关分组(DRG)医院报销方案下,医院的经济激励措施正在迅速变化。本项目的目的是研究一家大型学术医疗中心肾病科住院患者的资源使用情况、年龄和治疗结果。1985年1月1日至1986年12月31日期间,784例肾病科住院患者的总住院费用为5,037,460美元。每位患者的平均住院费用和死亡率通常随年龄增长而增加。对所分析的13个肾病科DRG中的患者进行DRG支付将产生总计483,584美元的损失;然而,所有55岁及以上年龄段的患者都产生了重大损失(最高的是85岁及以上的患者,每位患者损失5,343美元)。与非糖尿病肾病患者相比,糖尿病肾病患者消耗了更多资源,并且与没有慢性肾衰竭的同一DRG中的患者相比,患有慢性肾衰竭的内科和外科DRG中的患者也是如此。老年肾病患者的急诊和重症监护病房入院率以及血液需求量也高于年轻患者。这项研究表明,当前的DRG报销方案对于老年肾病患者以及患有糖尿病和慢性肾衰竭的患者可能是不公平的。DRG带来的经济抑制因素未来可能会影响肾病患者群体的医疗可及性和医疗质量。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验